Universal Registration Document

Overview

The report describes the company's first commercial sales of Aeson® in Europe in 2021, with seven commercial systems sold in Germany and Italy and three systems sold in the United States under the EFS. It reports 160 employees at year-end, an increase of 41 from the prior year. The company also continued its production ramp-up and clinical development while temporarily suspending implants after quality issues led to three serious adverse events, including two deaths.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2021
Period: Ends 31 December 2021
Publication date: 21 April 2022
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services